Israel Peripheral Neuropathy Market (2025-2031) | Outlook, Growth, Companies, Size & Revenue, Trends, Value, Competitive Landscape, Share, Segmentation, Analysis, Industry, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Peripheral Neuropathy Market Revenues & Volume, 2021 & 2031F

3.3 Israel Peripheral Neuropathy Market - Industry Life Cycle

3.4 Israel Peripheral Neuropathy Market - Porter's Five Forces

3.5 Israel Peripheral Neuropathy Market Revenues & Volume Share, By Treatment, 2021 & 2031F

3.6 Israel Peripheral Neuropathy Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F

3.7 Israel Peripheral Neuropathy Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 Israel Peripheral Neuropathy Market Revenues & Volume Share, By End-Users, 2021 & 2031F

3.9 Israel Peripheral Neuropathy Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of diabetes in Israel, a major cause of peripheral neuropathy

4.2.2 Growing geriatric population in Israel, who are more prone to developing peripheral neuropathy

4.2.3 Technological advancements in diagnostic tools and treatments for peripheral neuropathy

4.3 Market Restraints

4.3.1 High treatment costs associated with managing peripheral neuropathy

4.3.2 Limited awareness about peripheral neuropathy among the general population in Israel

4.3.3 Stringent regulatory policies governing the approval and marketing of neuropathy treatments in Israel

6.1 Israel Peripheral Neuropathy Market, By Treatment

6.1.1 Overview and Analysis

6.1.2 Israel Peripheral Neuropathy Market Revenues & Volume, By Treatment, 2021- 2031F

6.1.3 Israel Peripheral Neuropathy Market Revenues & Volume, By Pain Relievers, 2021- 2031F

6.1.4 Israel Peripheral Neuropathy Market Revenues & Volume, By Anti-Seizure Medications, 2021- 2031F

6.1.5 Israel Peripheral Neuropathy Market Revenues & Volume, By Antidepressants, 2021- 2031F

6.1.6 Israel Peripheral Neuropathy Market Revenues & Volume, By Others, 2021- 2031F

6.2 Israel Peripheral Neuropathy Market, By Therapy Type

6.2.1 Overview and Analysis

6.2.2 Israel Peripheral Neuropathy Market Revenues & Volume, By Transcutaneous Electrical Nerve Stimulation (TENS), 2021- 2031F

6.2.3 Israel Peripheral Neuropathy Market Revenues & Volume, By Physical Therapy, 2021- 2031F

6.2.4 Israel Peripheral Neuropathy Market Revenues & Volume, By Immunoglobulins, 2021- 2031F

6.2.5 Israel Peripheral Neuropathy Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Peripheral Neuropathy Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 Israel Peripheral Neuropathy Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 Israel Peripheral Neuropathy Market Revenues & Volume, By Parenteral, 2021- 2031F

6.3.4 Israel Peripheral Neuropathy Market Revenues & Volume, By Others, 2021- 2031F

6.4 Israel Peripheral Neuropathy Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 Israel Peripheral Neuropathy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.4.3 Israel Peripheral Neuropathy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.4.4 Israel Peripheral Neuropathy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.5 Israel Peripheral Neuropathy Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 Israel Peripheral Neuropathy Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

6.5.3 Israel Peripheral Neuropathy Market Revenues & Volume, By Online Pharmacy, 2021- 2031F

6.5.4 Israel Peripheral Neuropathy Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

7.1 Israel Peripheral Neuropathy Market Export to Major Countries

7.2 Israel Peripheral Neuropathy Market Imports from Major Countries

8.1 Average time taken for diagnosis of peripheral neuropathy in Israel

8.2 Number of clinical trials focused on developing new treatments for peripheral neuropathy in Israel

8.3 Patient satisfaction scores with the quality of care received for peripheral neuropathy in Israel

9.1 Israel Peripheral Neuropathy Market Opportunity Assessment, By Treatment, 2021 & 2031F

9.2 Israel Peripheral Neuropathy Market Opportunity Assessment, By Therapy Type, 2021 & 2031F

9.3 Israel Peripheral Neuropathy Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 Israel Peripheral Neuropathy Market Opportunity Assessment, By End-Users, 2021 & 2031F

9.5 Israel Peripheral Neuropathy Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 Israel Peripheral Neuropathy Market Revenue Share, By Companies, 2024

10.2 Israel Peripheral Neuropathy Market Competitive Benchmarking, By Operating and Technical Parameters